Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 8
Submit an article Journal homepage
2,419
Views
6
CrossRef citations to date
0
Altmetric
Neurology

Costs and resource use of community-dwelling patients with Alzheimer’s disease in Japan: 18-month results from the GERAS-J study

Miharu Nakanishia Research Center for Social Science and Medicine Tokyo Metropolitan. Institute of Medical Science, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0001-6200-9279
ORCID Icon,
Ataru Igarashib Department of Health Economics and Outcomes Research Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan;c Yokohama City University, Yokohama, Japan
,
Kaname Uedad Eli Lilly Japan K.K, Kobe, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1967-9829
ORCID Icon,
Alan J. M. Brnabice Eli Lilly Australia Pty, Limited, West Ryde, Sydney, Australia
,
Taka Matsumurad Eli Lilly Japan K.K, Kobe, Japan
,
Kenichi Megurof Geriatric Behavioral Neurology Project, New Industry Creation Hatchery Center, and Division of Nuclear Medicine, Cyclotron Radioisotope Center, Tohoku University, Sendai, Japan;g Osaki-Tajiri SKIP Center, Osaki, Japan
,
Masahito Yamadah Department of Neurology and Neurobiology of Aging, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, JapanORCID Iconhttps://orcid.org/0000-0003-2416-5662
ORCID Icon,
Masaru Mimurai Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan
,
Heii Araij ALZCLINIC TOKYO, Tokyo, Japan
&
Tamas Treuerk Eli Lilly and Company, Budapest, Hungary
 show all
Pages 1331-1339 | Received 15 Nov 2020, Accepted 23 Apr 2021, Published online: 20 May 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kristian Steen Frederiksen, Xavier Morato Arus, Henrik Zetterberg, Serge Gauthier, Mercè Boada, Vanesa Pytel, Julie Hahn-Pedersen, Luis Rafael Solís Tarazona & Soeren Mattke. (2024) Focusing on earlier diagnosis of Alzheimer's disease. Future Neurology 19:1.
Read now
Ataru Igarashi & Shunya Ikeda. (2022) Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview. Expert Review of Pharmacoeconomics & Outcomes Research 22:8, pages 1163-1170.
Read now
Tetsumasa Kamei, Hiroyuki Kobayashi, Maika Nishida, Kenzo Muramoto & Shohei Nishimoto. (2021) Effect of Psychoeducational Intervention on Donepezil Retention Rate and Analysis of Reasons for the Discontinuation in Patients with Alzheimer’s Dementia: A Randomized Study. Patient Preference and Adherence 15, pages 2103-2111.
Read now

Articles from other publishers (3)

Lyn Xuan Tay, Siew Chin Ong, Lynn Jia Tay, Trecia Ng & Thaigarajan Parumasivam. (2024) Economic Burden of Alzheimer’s Disease: A Systematic Review. Value in Health Regional Issues 40, pages 1-12.
Crossref
Kristian Steen Frederiksen, Krista L. Lanctôt, Wendy Weidner, Julie Hviid Hahn-Pedersen & Soeren Mattke. (2023) A Literature Review on the Burden of Alzheimer’s Disease on Care Partners. Journal of Alzheimer's Disease 96:3, pages 947-966.
Crossref
Ataru Igarashi, Mie Kasai Azuma, Quanwu Zhang, Weicheng Ye, Aditya Sardesai, Henri Folse, Ameya Chavan, Kiyoyuki Tomita & Amir Abbas Tahami Monfared. (2023) Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation. Neurology and Therapy 12:4, pages 1133-1157.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.